Cargando…

Attitudes towards lung cancer screening in a population sample

BACKGROUND: Lung cancer is the leading cause of cancer death worldwide. Routine UK lung cancer screening is not yet available, thus understanding barriers to participation in lung screening could help maximize effectiveness if introduced. METHODS: Population‐based survey of 1007 adults aged 16 and o...

Descripción completa

Detalles Bibliográficos
Autores principales: Smits, Stephanie E., McCutchan, Grace M., Hanson, Jane A., Brain, Kate E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250881/
https://www.ncbi.nlm.nih.gov/pubmed/30085384
http://dx.doi.org/10.1111/hex.12819
_version_ 1783372999310704640
author Smits, Stephanie E.
McCutchan, Grace M.
Hanson, Jane A.
Brain, Kate E.
author_facet Smits, Stephanie E.
McCutchan, Grace M.
Hanson, Jane A.
Brain, Kate E.
author_sort Smits, Stephanie E.
collection PubMed
description BACKGROUND: Lung cancer is the leading cause of cancer death worldwide. Routine UK lung cancer screening is not yet available, thus understanding barriers to participation in lung screening could help maximize effectiveness if introduced. METHODS: Population‐based survey of 1007 adults aged 16 and over in Wales using random quota sampling. Computer‐assisted face‐to‐face interviews included demographic variables (age, gender, smoking, social group), four lung cancer belief statements and three lung screening attitudinal items. Determinants of lung screening attitudes were examined using multivariable regression adjusted for age, gender, social group and previous exposure to lung campaign messages. RESULTS: Avoidance of lung screening due to fear of what might be found was statistically significantly associated with negative lung cancer beliefs including fatalism (aOR = 8.8, 95% CI = 5.6‐13.9, P ≤ 0.001), low perceived value of symptomatic presentation (aOR = 2.4, 95% CI = 1.5‐3.9, P ≤ 0.001) and low treatment efficacy (aOR = 0.3, CI = 0.2‐0.7, P ≤ 0.01). Low perceived effectiveness of lung screening was significantly associated with fatalism (aOR = 6.4, 95% CI = 3.5‐11.7, P ≤ 0.001), low perceived value of symptom presentation (aOR = 4.9, 95% CI = 2.7‐8.9, P ≤ 0.001) and low treatment efficacy (aOR = 0.1, 95% CI = 0.1‐0.3, P ≤ 0.001). In contrast, respondents who thought lung screening could reduce cancer deaths had positive beliefs about lung cancer (aOR = 0.4, 95% CI = 0.2‐0.7, P ≤ 0.001) and its treatment (aOR = 6.1, 95% CI = 3.0‐12.6, P ≤ 0.001). CONCLUSION: People with negative beliefs about lung cancer may be more likely to avoid lung screening. Alongside the introduction of effective early detection strategies, interventions are needed to modify public perceptions of lung cancer, particularly for fatalism.
format Online
Article
Text
id pubmed-6250881
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-62508812018-12-01 Attitudes towards lung cancer screening in a population sample Smits, Stephanie E. McCutchan, Grace M. Hanson, Jane A. Brain, Kate E. Health Expect Original Research Papers BACKGROUND: Lung cancer is the leading cause of cancer death worldwide. Routine UK lung cancer screening is not yet available, thus understanding barriers to participation in lung screening could help maximize effectiveness if introduced. METHODS: Population‐based survey of 1007 adults aged 16 and over in Wales using random quota sampling. Computer‐assisted face‐to‐face interviews included demographic variables (age, gender, smoking, social group), four lung cancer belief statements and three lung screening attitudinal items. Determinants of lung screening attitudes were examined using multivariable regression adjusted for age, gender, social group and previous exposure to lung campaign messages. RESULTS: Avoidance of lung screening due to fear of what might be found was statistically significantly associated with negative lung cancer beliefs including fatalism (aOR = 8.8, 95% CI = 5.6‐13.9, P ≤ 0.001), low perceived value of symptomatic presentation (aOR = 2.4, 95% CI = 1.5‐3.9, P ≤ 0.001) and low treatment efficacy (aOR = 0.3, CI = 0.2‐0.7, P ≤ 0.01). Low perceived effectiveness of lung screening was significantly associated with fatalism (aOR = 6.4, 95% CI = 3.5‐11.7, P ≤ 0.001), low perceived value of symptom presentation (aOR = 4.9, 95% CI = 2.7‐8.9, P ≤ 0.001) and low treatment efficacy (aOR = 0.1, 95% CI = 0.1‐0.3, P ≤ 0.001). In contrast, respondents who thought lung screening could reduce cancer deaths had positive beliefs about lung cancer (aOR = 0.4, 95% CI = 0.2‐0.7, P ≤ 0.001) and its treatment (aOR = 6.1, 95% CI = 3.0‐12.6, P ≤ 0.001). CONCLUSION: People with negative beliefs about lung cancer may be more likely to avoid lung screening. Alongside the introduction of effective early detection strategies, interventions are needed to modify public perceptions of lung cancer, particularly for fatalism. John Wiley and Sons Inc. 2018-08-07 2018-12 /pmc/articles/PMC6250881/ /pubmed/30085384 http://dx.doi.org/10.1111/hex.12819 Text en © 2018 The Authors Health Expectations published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research Papers
Smits, Stephanie E.
McCutchan, Grace M.
Hanson, Jane A.
Brain, Kate E.
Attitudes towards lung cancer screening in a population sample
title Attitudes towards lung cancer screening in a population sample
title_full Attitudes towards lung cancer screening in a population sample
title_fullStr Attitudes towards lung cancer screening in a population sample
title_full_unstemmed Attitudes towards lung cancer screening in a population sample
title_short Attitudes towards lung cancer screening in a population sample
title_sort attitudes towards lung cancer screening in a population sample
topic Original Research Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250881/
https://www.ncbi.nlm.nih.gov/pubmed/30085384
http://dx.doi.org/10.1111/hex.12819
work_keys_str_mv AT smitsstephaniee attitudestowardslungcancerscreeninginapopulationsample
AT mccutchangracem attitudestowardslungcancerscreeninginapopulationsample
AT hansonjanea attitudestowardslungcancerscreeninginapopulationsample
AT brainkatee attitudestowardslungcancerscreeninginapopulationsample